Bed, Bath & Beyond Exec's Death Followed Allegations Of Fraud

The unexpected death of Bed, Bath & Beyond's former chief financial officer amid allegations of fraud against him raises further questions about the struggling chain.

Gustavo Arnal died Friday after jumping from a luxury skyscraper in downtown Manhattan. The New York City medical examiner's office ruled his death a suicide.

The death of the 52-year-old executive comes as the once-popular retailer, whose sales and stock price have plunged since last year, struggles to turn itself around. Arnal is also named as a defendant in a securities lawsuit that accuses him, his employer and billionaire entrepreneur Ryan Cohen of a pump-and-dump scheme to inflate Bed, Bath & Beyond stock.

Bed, Bath & Beyond did not respond to a request for comment. On its website, the company called Arnal's death a "shocking loss." 

"Gustavo will be remembered by all he worked with for his leadership, talent and stewardship of our Company. I am proud to have been his colleague, and he will be truly missed by all of us at Bed Bath & Beyond and everyone who had the pleasure of knowing him," Harriet Edelman, the company's chair, said in a statement. 

GameSpot, where Cohen is chairman, also did not respond to a request for comment.

A stock shock — then a lawsuit

Bed, Bath & Beyond shares have been on a roller coaster, soaring during the "meme stock" frenzy of 2020 before fading last year. The stock surged again in March when Cohen, the founder of online pet products company Chewy.com, revealed a nearly 10% stake in the company.

Cohen is credited with engineering a turnaround at GameStop, and his ownership was seen by some retail investors as a positive signal for Bed, Bath & Beyond. To kick-start the home goods company's recovery, he quickly helped usher Bed, Bath & Beyond's CEO and chief marketing officer out the door and appointed two new directors.

Cohen filed more paperwork with the Securities and Exchange Commission on August 16, re-stating his ownership of Bed, Bath & Beyond. That led the stock to surge once again. But that same day, Cohen immediately started selling his stake, prompting a sell-off that drove the company's stock to one-third iits original price within a week.

That prompted some to call for an investigation by the SEC, and on August 23 a shareholder suit was filed in Washington, D.C., district court, alleging securities fraud.

The suit, which is seeking class-action status, claims that Cohen, Arnal, JPMorgan and others "engaged in a fraudulent scheme to artificially inflate the price of BBBY publicly traded stock" and "blatantly misrepresented the value and profitability of BBBY" to entice retail investors to buy shares. 

According to the lawsuit, Cohen and Arnal cooked up a scheme whereby Cohen would hype the company's stock publicly while Arnal would limit stock sales by insiders, driving up its price. The complaint also claims that Cohen lied when he re-stated his ownership of the company and alleged that he had started selling his stock at that point. 

Arnal also sold 55,000 shares of Bed, Bath & Beyond on August 16, although his disclosure states that the plan to sell started in April. 

Cohen and Arnal "engaged in illegal insider trading and fraudulent SEC reporting," the suit claims. It also alleges that the two "took advantage of the inflated stock price and used fraudulent and misleading SEC filings to sell all their BBBY shares and options at artificially inflated prices to unsuspecting and innocent public investors and then retained control of the profit." 

Bed, Bath & Beyond told investors in an August 31 securities filing that "The company is in the early stages of evaluating the complaint, but based on current knowledge the company believes the claims are without merit." 

Leadership void

Even before the shareholder suit, Wall Street's view of Bed, Bath & Beyond had turned sour. Analysts at Wedbush downgraded the stock after Cohen's move to liquidate his stake, calling the price "disconnected" from the company's fundamentals. 

"Bed, Bath & Beyond "finds itself in an unenviable position as it faces steep market share losses, an overabundance of inventory and dwindling cash reserves," they wrote. "Even if [Bed, Bath & Beyond] manages to make progress against some of its operational goals in the coming quarters, we see the current risk/reward as disproportionately skewed to the downside."

The retailer last week secured $500 million of new financing and outlined another turnaround plan that includes closing 150 stores, slashing one-fifth of staff and cutting down on store brands. It is still searching for a new CEO and chief marketing officer. 

Bed, Bath & Beyond's price has fallen 68% over the last year, closing Friday at $8.63.